RiverVest Venture Fund IV L.P. 13D/13G Filings for

RiverVest Venture Fund IV L.P. 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2020-12-22
4:01 pm
Unchanged		2020-12-1713DMirum Pharmaceuticals, Inc.
MIRM		RiverVest Venture Fund IV L.P.1,921,118
6.600%		0
(Unchanged)		Filing